<DOC>
	<DOCNO>NCT00541775</DOCNO>
	<brief_summary>The purpose study test safety effectiveness sitagliptin patient type 2 diabetes .</brief_summary>
	<brief_title>Safety/Efficacy Sitagliptin Patient w/ Type 2 Diabetes ( 0431-801 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient Type 2 diabetes Currently take metformin &gt; 1500 mg/day least 10 week Male female Patient peripheral edema History type 1 diabetes Patient require insulin within prior 8 week Have participate currently participate another study investigational compound device within 12 week start study Participating weight loss program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>